South Korean aesthetic device maker Wontech has obtained Mexican regulatory approvals for its skin regeneration system Lavieen and vascular/pigment lesion laser V-Laser, the company announced on June 2. The move establishes a dual-hub strategy in Brazil and Mexico, which together account for over half of the Latin American medical aesthetics market. For overseas distributors and clinics, this signals a growing portfolio of validated devices entering a high-demand region.
Regulatory milestone
Wontech received Mexican clearance for both Lavieen and V-Laser, adding to its earlier approvals in Brazil. The V-Laser operates at 1064nm and 532nm dual wavelengths, used for soft tissue incision, excision, ablation, hemostasis, and coagulation. With these approvals, Wontech can address skin rejuvenation, pigmentation, and vascular lesion treatment needs across Latin America.
Market strategy and pre-launch activities
Before securing the approvals, Wontech engaged a local distributor and conducted pre-sales activities. Last month, the company invited 15 Mexican medical professionals to South Korea for V-Laser training, preparing the ground for market entry. This hands-on approach aims to build clinical confidence and accelerate adoption.
Global footprint
Over 70% of Wontech's revenue comes from overseas. The company holds certifications from the US FDA, European CE, Australian TGA, and Thailand FDA, supplying products to more than 80 countries. Its subsidiaries in the US, Japan, China, and Thailand drive global expansion.
What buyers should watch
Distributors and clinics in Latin America should note Wontech's commitment to building clinical references and educational programs in Brazil and Mexico. The company plans to expand training, academic activities, and marketing initiatives across the region, potentially opening partnership opportunities for device procurement and service support.
Sourcing context
Wontech's dual-hub approach in Latin America's two largest markets reduces logistical and regulatory barriers for regional buyers. Clinics seeking versatile laser platforms for both aesthetic and surgical applications may find the V-Laser's dual-wavelength capability a practical addition to their device lineup.
Source: Read the original report | Published: June 02, 2026